Millennium Licenses Lexicon Technology

Jun 07, 2002

NEW YORK, June 7-Lexicon Genetics has granted a license to its isogenic DNA technology to Millennium Pharmaceuticals, the company said yesterday.

The license, which is nonexclusive, will allow Millennium to use the technology in drug discovery and target validation.

Financial details were not disclosed.

Lexicon, based in The Woodlands, Tx., has developed a range of techniques to improve gene knockout technology.

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.